HMGB1, S100A9, and HSP90 were shown to be predictive and prognostic markers for distinguishing cancer patients from healthy controls in several cancer types such as mesothelioma, colorectal, gastric, and lung cancers [18,19,20,21]. This evidence concerns the gene S100A9 and cancer.